Oragenics Chases Vaccine for Niche Markets

UF startup and UF Innovate | Sid Martin Biotech graduate Oragenics, a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, seeks to be a major player in the Super Bowl of the pharmaceutical industry: a COVID-19 vaccine.

Oragenics Inc. and Aragen Bioscience Enter Agreement to Accelerate Development of TerraCoV2, a COVID 19 Vaccine Candidate

UF startup and UF Innovate | Sid Martin Biotech graduate company Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, announced that through its wholly-owned subsidiary, Noachis Terra, it has entered into an agreement with Aragen Bioscience, a leading contract research organization focused on accelerating pre-clinical biologics product […]

After Acquisition, Tampa Biotech Firm Looks Toward COVID-19 Vaccine

Serendipity is the word Alan Joslyn uses to describe the meeting and eventual acquisition of a Gainesville-based biotech firm. “It’s not every day all of a sudden a private company falls in your lap that’s working in COVID-19,” said Alan Joslyn, CEO of UF startup and UF Innovate | Sid Martin Biotech graduate company Oragenics, Inc., a leader in […]

Oragenics Acquires Noachis Terra Inc., to Develop Its TerraCoV2 NIH-Generated SARS-CoV-2 (COVID 19) Vaccine Candidate Utilizing “Spike Protein”

UF startup and UF Innovate | Sid Martin Biotech graduate company Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, announced its acquisition of UF Innovate | The Hub resident client Noachis Terra Inc., following its entry into a stock purchase agreement, to develop and […]

Biotech Firm Picks Gainesville As It Seeks COVID-19 Vaccine

Noachis Terra Inc., a new biotechnology company that will focus its efforts on the development of a vaccine for COVID-19 announced its headquarters will be located in Gainesville at UF Innovate | The Hub. Interim President Gary Ascani said the company is working on proposals to public and private investors who to help develop a […]